Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To determine the safety, tolerability and efficacy (in terms of response rate and progression-free survival) of the combination in patients with metastatic CRC resistant to or unsuitable for treatment with 5-fluorouracil and irinotecan and/or oxaliplatin.
Critère d'inclusion
- Metastatic Colorectal Cancer resistant to or unsuitable for treatment with 5-fluorouracil and irinotecan and/or oxaliplatin